Past Results
For the past 30 years, Weitz & Luxenberg has represented victims of asbestos exposure, defective drugs and medical devices, environmental pollution, consumer fraud, and personal injury. In that time, W&L has secured more than $17 billion in verdicts and settlements for our clients.
Recent verdicts
& settlements
Recent Verdicts
Weitz & Luxenberg has been one of the most successful law firms representing clients exposed to asbestos, recovering $8.5 billion over the past 30 years. We have a 500-member team of attorneys and support staff dedicated to helping our clients receive the maximum amount of compensation for their injuries. We have negotiated billion-dollar settlements for defective drugs and devices, and environmental pollution victims, and helped those harmed by consumer fraud and accidents receive millions in compensation. To see what we have done for our clients, read about our top results.
CATEGORY: drugs & DevicesPast Results
NOV. 3, 2014
On November 3, 2014, a global settlement program involving Stryker’s Rejuvenate and ABGII modular hip implants was executed before and announced by Superior Court Judge Brian R. Martinotti in Bergen County, New Jersey. The settlement was finalized after four months of negotiations before retired United States Magistrate Judge Diane Welsh of JAMS in Philadelphia. Stryker…
On November 3, 2014, a global settlement program involving Stryker’s Rejuvenate and ABGII modular hip implants was executed before and announced by Superior Court Judge Brian R. Martinotti in Bergen County, New Jersey. The settlement was finalized after four months of negotiations before retired United States Magistrate Judge Diane Welsh of JAMS in Philadelphia. Stryker and plaintiffs’ counsel appointed by Judge Martinotti —Ellen Relkin of Weitz & Luxenberg, NYC; Cal Warriner of Searcy Denney, West Palm Beach, FL; Thomas R. Anapol of Anapol Schwartz, Philadelphia; and Tara Sutton of Minneapolis-based Robins Kaplan Miller & Ciresi L.L.P —reached agreement on behalf of an estimated 3000 patients who were implanted with the modular Rejuvenate or ABGII implants and have undergone a revision surgery. Counsel from the parallel federal Multi-District Litigation proceedings in Minnesota subsequently joined the negotiations and are signatories to the Agreement. Tobias Millrood and David Buchanan, the other members of the NJ PSC, played key roles advancing the discovery and bellwether trial process, serving as a catalyst to the settlement.
The settlement provides for gross base awards of $300,000 per failed implant and provides for significant additional compensation for claimants who suffered complications during revision surgery and for other damages, including future surgeries caused by complications. The settlement also provides compensation for individuals who need a revision but are medically unable to undergo the surgery. There is no overall cap or fixed fund for Stryker’s liability under this settlement program, and the settlement payments are expected to exceed $1 billion. Claimants will begin receiving their awards the summer of 2015.
Stryker Orthopedics of Mahwah, New Jersey issued a voluntary recall of its modular Stryker Rejuvenate and ABGII hip stems on July 3, 2012, due to fretting and corrosion near the modular neck-stem junction of the implant that results in adverse tissue reactions, metallosis, necrosis, and the need for revision surgeries. The first lawsuit against Stryker Orthopedics was filed in Bergen County in August of 2012. On January 15, 2013, the New Jersey Supreme Court designated the Stryker litigation as Multi-County litigation and assigned all of the individual cases to Judge Martinotti.
Early in the litigation process, Judge Martinotti established a unique, bellwether mediation process that resulted in individual settlements of 21 cases. The parties credit the NJ bellwether mediation process as precipitating the lengthy negotiations and, ultimately, the global settlement.
The Settlement Oversight Committee of the New Jersey Plaintiff Steering Committee directs interested parties to Stryker’s official settlement website at http://www.strykermodularhipsettlement.com/ as well as to the website of the NJ PSC at http://RejuvenateHipSettlement.com for additional information and a copy of the full settlement agreement.
LOOKING FOR LEGAL HELP?
We would feel privileged to assist you.
For a free case review, please contact us today.
Asbestos Information
CATEGORY: drugs & DevicesPast Results
MAY 20, 2014
Thousands of patients whose hip implants failed and were removed prior to August 31, 2013 and who enrolled in the $2.5 billion settlement will begin to receive their settlement payments. Late last week, DePuy and its parent company Johnson & Johnson agreed to waive its ”walk-away rights” and are proceeding to fund the six-figure settlements…
Thousands of patients whose hip implants failed and were removed prior to August 31, 2013 and who enrolled in the $2.5 billion settlement will begin to receive their settlement payments. Late last week, DePuy and its parent company Johnson & Johnson agreed to waive its ”walk-away rights” and are proceeding to fund the six-figure settlements in light of the vast majority of eligible patients choosing to enroll in the settlement.
Most of the claimants will receive the base pay of their settlement this summer. The standard base payment is $250,000 although it can be reduced under certain limited circumstances.
Virtually unprecedented in the settlement is DePuy’s responsibility to separately reimburse Medicare and other health insurance providers for the cost of the revision surgery and related care, which typically costs $50,000 and upward. Certain clients with extraordinary injuries will be eligible for additional compensation beyond the base award.
Weitz & Luxenberg’s Ellen Relkin, co-lead counsel for the DePuy ASR Multi-District Litigation, worked for many months with the negotiating team in reaching the settlement’s terms. Now, hundreds of the firm’s clients, along with thousands of others, stand to have their cases resolved.
Other DePuy ASR recipients who have already retained W&L but did not qualify for the pending settlement program because the implant was removed after August 31, 2013 or has not been removed yet will continue to pursue their claims against Johnson & Johnson.
Relkin stresses that Weitz & Luxenberg’s is still able to accept new DePuy ASR and other defective hip cases, and encourages patients with potentially defective or revised hip implants to contact the firm.
LOOKING FOR LEGAL HELP?
We would feel privileged to assist you.
For a free case review, please contact us today.
Asbestos Information
CATEGORY: drugs & DevicesPast Results
APR. 9, 2014
A Louisiana jury has awarded $9 billion to a New York man who developed bladder cancer after taking Actos. The verdict, issued Monday night, orders Takeda Pharmaceuticals to pay $6 billion in punitive damages, and Eli Lilly to pay $3 billion. Plaintiff Terrence Allen, a New York resident, was diagnosed with bladder cancer in 2011…
We are no longer accepting new cases.
A Louisiana jury has awarded $9 billion to a New York man who developed bladder cancer after taking Actos. The verdict, issued Monday night, orders Takeda Pharmaceuticals to pay $6 billion in punitive damages, and Eli Lilly to pay $3 billion.
Plaintiff Terrence Allen, a New York resident, was diagnosed with bladder cancer in 2011 after taking Actos for more than four years. Mr. Allen and wife Susan brought the suit against Takeda, a Japanese pharmaceutical group, and Lilly, a pharmaceutical company based in Indianapolis, claiming the companies failed to warn that taking the drug could increase the risk of cancer. Mr. Allen’s case was the first lawsuit filed in the Actos Multi-District Litigation.
Actos, which was manufactured by Takeda and marketed in the US by Lilly, has been widely used since 1999 by diabetics to control blood sugar levels. The drug is FDA-approved, but several safety studies have revealed a link between the drug and an increased risk for bladder cancer.
Allen’s suit claimed that Takeda and Lilly continued to manufacture and market the drug despite learning of the drug’s danger and failed to relay the bladder cancer risk to the medical community.
The verdict, delivered by a jury of eight, found Takeda and Lilly responsible and issued the $9 billion verdict. The verdict also ordered $1.475 million in compensatory damages.
Weitz & Luxenberg’s Paul J. Pennock, co-lead counsel for the plaintiffs, said he was glad to see his clients achieve justice. “I am extremely happy the Jury sent this message to Takeda and Eli Lilly, as well as other pharmaceutical companies who would put their consumers at risk,” said Pennock. “At the same time, there are hundreds of others who were injured by Actos. They all deserve the same justice, so we have a long fight ahead of us.”
The trial (Allen et al. v. Takeda Pharmaceutical Co., # 6:12-cv-00064) was filed in the U.S. District Court for the Western District of Louisiana.
LOOKING FOR LEGAL HELP?
We would feel privileged to assist you.
For a free case review, please contact us today.
Asbestos Information
CATEGORY: drugs & DevicesPast Results
APR. 5, 2006
Weitz & Luxenberg client John McDarby, 77, and his wife were rewarded a $4.5 million dollar verdict and $9 million in punitive damages from a New Jersey jury in one of the first Vioxx trial cases against Merck. ”The verdict is a victory for the 100,000 Americans who had heart attacks from Vioxx,” said lawyer Robert Gordon.…
Weitz & Luxenberg client John McDarby, 77, and his wife were rewarded a $4.5 million dollar verdict and $9 million in punitive damages from a New Jersey jury in one of the first Vioxx trial cases against Merck.
”The verdict is a victory for the 100,000 Americans who had heart attacks from Vioxx,” said lawyer Robert Gordon. John McDarby, who suffers from diabetes, had a heart attack after taking Vioxx for four years. He was in his living room, and broke a hip as a result, leaving him dependent on a wheelchair and causing a marked decline in his health.
The jury has now determined that Merck should pay $9 million in punitive damages, bringing the total to $13.5 million. ”This is a victory for the tens of thousands of doctors who were lied to by Merck about the dangers of Vioxx,” said Rob Gordon.
Attorney Jerry Kristal said: ”This is a victory for all of the John and Irma McDarbys of the world, people who are taking medications every single day, who now have at least a chance of making sure that the companies that are making those medications are going to do the right thing.”
”Given that this was the first punitive damage trial in a pharmaceutical case in New Jersey since the legislature adopted the drug lobby’s special protective legislation, there was no legal precedent on how to address these key issues,” explains Weitz & Luxenberg attorney Ellen Relkin.
Weitz & Luxenberg is representing thousands of individuals who were affected by Vioxx.
LOOKING FOR LEGAL HELP?
We would feel privileged to assist you.
For a free case review, please contact us today.
Asbestos Information
CATEGORY: ENVIRONMENTALPast Results
JUL. 27, 2021
Attorneys from Weitz & Luxenberg were co-leaders on the team that secured the proposed $65.25 million settlement for the Hoosick Falls community whose drinking…
Attorneys from Weitz & Luxenberg were co-leaders on the team that secured the proposed $65.25 million settlement for the Hoosick Falls community whose drinking water supply is contaminated by PFOA (perfluorooctanoic acid). This settlement helps to compensate people living in Hoosick Falls for the losses and injuries they sustained from exposure to the toxic chemical PFOA, sometimes referred to as the “forever chemical.”
The defendants, Saint-Gobain Performance Plastics Corp., 3M Co., and Honeywell International Inc., have agreed to a proposed class settlement for the residents. The remaining defendant, E.I. DuPont de Nemours & Co., is not participating in the settlement.
This settlement agreement is for the case Michelle Baker et al. v. Saint-Gobain Performance Plastics Corp. et al., currently pending in the U.S. District Court for the Northern District of New York. Saint-Gobain and Honeywell were accused of mishandling the PFOA. 3M and DuPont were accused of manufacturing it knowing that it would contaminate the environment and injure people.
Financial Compensation and Medical Monitoring
There are four settlement classes. The payout amounts are broken up by class: (1)
- Approximately $21 million for residents in the Municipal Water Property Settlement Class or Private Well Water Property Settlement Class.
- Almost $8 million for residents in the Nuisance Settlement Class.
- Nearly $23 million for residents in the Medical Monitoring Settlement Class.
The settlement includes a significant medical monitoring program. Monitoring services are being provided for 10 years. The program tests for PFOA exposure and evaluates people for potential disease from exposure to the toxic chemical.
Another key aspect of the settlement is that people can still sue for illnesses in the future caused by PFOA. The chemical PFOA has been recognized as potentially causing a number of illnesses.
These include a range of adverse health events such as increased risk of cancers, developmental issues, reproductive problems, and immunological effects. Other potential illnesses include high cholesterol, ulcerative colitis, thyroid disease, and preeclampsia/pregnancy-induced hypertension. (2) (3)
PFOA Is a Forever Chemical
Robin L. Greenwald, head of Weitz & Luxenberg’s Environmental, Toxic Tort & Consumer Protection Unit, asserts that “Dangerous chemicals, such as PFOAs, are ‘forever chemicals’ that remain in drinking water supplies and in your body. When corporations manufacture products, and their processes cause these toxic chemicals to escape into the environment, property values decrease and people are at risk of serious illness.”
Attorneys from Weitz & Luxenberg are part of a team who negotiated the proposed settlement reached. The plaintiffs are represented by a group consisting of Ms. Greenwald, James J. Bilsborrow of Seeger Weiss LLP, Stephen Schwarz and Hadley L. Matarazzo of Faraci Lange LLP and Gerald Williams of Williams Cedar LLC.
Honeywell and Saint-Gobain began funding water treatment systems to remove PFOA from the drinking water supply after the case was filed. Honeywell indicated PFOA has not been detected in the municipal water supply since March 2016. (4)
“It is fair and just that large corporations such as these defendants pay for the injuries they caused our clients. Not only did these companies put PFOA into the environment, but they knew of the risks and never let the people actually drinking the water know. They deserve to pay for their callous disregard of the residents of Hoosick Falls,” declares Ms. Greenwald.
Hoosick Falls Case Background
The Village of Hoosick Falls is a small town in central upstate New York. There were once a number of manufacturing plants in the area.
The facilities used PFOA during their manufacturing processes. PFOA is in Teflon products, including pots and pans, in addition to a number of other consumer products. These include treatments to make fabric and clothing resist stains and spills. Waste was discharged from these companies, putting PFOA into the water and environment.
The PFOA in the Hoosick Falls water supply exceeded the levels the U.S. Environmental Protection Agency (EPA) considered safe. The EPA recommended that residents not drink the water or use it for cooking. (5)
A facility on McCaffrey Street used a foam containing PFOA for more than 30 years. The foam polluted the groundwater and the air. The facility was owned by Honeywell and now is owned by Saint-Gobain.
Teflon products were manufactured at the facility by 3M and DuPont. The lawsuit claims that these companies knew about the PFOA health risks, but failed to warn the residents in the area about them.
Toxic Chemical Lawsuit Wins
Weitz & Luxenberg attorneys have a relevant history of settling and winning toxic substances exposure lawsuits. Other significant wins for our clients include a $423 million settlement against large oil companies for contaminating public water systems with MTBE (methyl tertiary butyl ether).
Ms. Greenwald also was co-lead counsel in the Roundup weed killer litigation and the settlement against Monsanto for clients diagnosed with the cancer Non-Hodgkin Lymphoma after exposure to glyphosate.
Ms. Greenwald also served a major role in achieving an $18.7 billion settlement with BP for the Gulf of Mexico oil spill, a disaster affecting large swathes of the Gulf Coast population and environment.
View Sources
- Angell. M. Law360 (2021, July 22). Saint-Gobain, 3M, Honeywell To Pay $65M Over Tainted Water. Retrieved from: https://www.law360.com/articles/1405504/saint-gobain-3m-honeywell-to-pay-65m-over-tainted-water
- Ibid.
- Lyons, B.J. Times Union. (2021, July 23). $65 million settlement filed in Hoosick Falls PFOA water contamination. Retrieved from: https://www.timesunion.com/state/article/hoosick-falls-pfoa-settlement-16326755.php
- Angell. M. Law360 (2021, July 22). Saint-Gobain, 3M, Honeywell To Pay $65M Over Tainted Water. Retrieved from: https://www.law360.com/articles/1405504/saint-gobain-3m-honeywell-to-pay-65m-over-tainted-water
- United States Environmental Protection Agency. (2016, January 12). Hoosick Falls, New York Drinking Water and Groundwater Contamination Frequently Asked Questions. Retrieved from: https://www.epa.gov/sites/default/files/2016-01/documents/hoosickfalls_faqs.pdf
LOOKING FOR LEGAL HELP?
We would feel privileged to assist you.
For a free case review, please contact us today.
Asbestos Information